Dosing underway for ALX Oncology's ALX148 in mid-stage blood cancer study
Dosing underway for ALX Oncology's ALX148 in mid-stage blood cancer study
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..